Biodel, stem-cell biotechs lead drug stock south
BOSTON (MarketWatch) -- Biodel Inc. led drug stocks south early Tuesday as shares of the biotech company fell on news that the U.S. Food and Drug Administration has issued a warning letter to one of its contract product manufacturers.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here